| Covidien Changes Optimark Label To Include Renal Risk - Update - RTT News |
|
|
RTT NewsThe FDA recommended the avoidance of GBCAs in patients with severe renal impairment, in 2007. "In addition, the FDA will hold a joint Advisory Committees ... read more |